相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Adenylate kinase 4 modulates oxidative stress and stabilizes HIF-1 to drive lung adenocarcinoma metastasis
Yi-Hua Jan et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Enhanced Glycolysis Supports Cell Survival in EGFR-Mutant Lung Adenocarcinoma by Inhibiting Autophagy-Mediated EGFR Degradation
Ji Hye Kim et al.
CANCER RESEARCH (2018)
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
Zefang Tang et al.
NUCLEIC ACIDS RESEARCH (2017)
Adenylate kinase hCINAP determines self-renewal of colorectal cancer stem cells by facilitating LDHA phosphorylation
Yapeng Ji et al.
NATURE COMMUNICATIONS (2017)
Cancer Statistics, 2016
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Modulation of anti-cancer drug sensitivity through the regulation of mitochondrial activity by adenylate kinase 4
Koichi Fujisawa et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2016)
The ATPase hCINAP regulates 18S rRNA processing and is essential for embryogenesis and tumour growth
Dongmei Bai et al.
Nature Communications (2016)
LKB1 Inactivation Elicits a Redox Imbalance to Modulate Non-small Cell Lung Cancer Plasticity and Therapeutic Response
Fuming Li et al.
CANCER CELL (2015)
Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials
James Chih-Hsin Yang et al.
LANCET ONCOLOGY (2015)
NRF2 regulates serine biosynthesis in non-small cell lung cancer
Gina M. DeNicola et al.
NATURE GENETICS (2015)
The prognostic landscape of genes and infiltrating immune cells across human cancers
Andrew J. Gentles et al.
NATURE MEDICINE (2015)
The many isoforms of human adenylate kinases
Christakis Panayiotou et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2014)
Epidermal Growth Factor Receptor ( EGFR) Signaling Regulates Global Metabolic Pathways in EGFR-mutated Lung Adenocarcinoma
Hideki Makinoshima et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Foxm1 transcription factor is required for the initiation of lung tumorigenesis by oncogenic KrasG12D
I-C Wang et al.
ONCOGENE (2014)
Transdifferentiation of lung adenocarcinoma in mice with Lkb1 deficiency to squamous cell carcinoma
Xiangkun Han et al.
NATURE COMMUNICATIONS (2014)
A Mitochondrial RNAi Screen Defines Cellular Bioenergetic Determinants and Identifies an Adenylate Kinase as a Key Regulator of ATP Levels
Nathan J. Lanning et al.
CELL REPORTS (2014)
NKX2-1/TTF-1: An Enigmatic Oncogene that Functions as a Double-Edged Sword for Cancer Cell Survival and Progression
Tomoya Yamaguchi et al.
CANCER CELL (2013)
Adenosine Nucleotide Biosynthesis and AMPK Regulate Adult Life Span and Mediate the Longevity Benefit of Caloric Restriction in Flies
Drew Stenesen et al.
CELL METABOLISM (2013)
Impact of EGFR Inhibitor in Non-Small Cell Lung Cancer on Progression-Free and Overall Survival: A Meta-Analysis
Chee Khoon Lee et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
SurvExpress: An Online Biomarker Validation Tool and Database for Cancer Gene Expression Data Using Survival Analysis
Raul Aguirre-Gamboa et al.
PLOS ONE (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
Ectopic Activation of Germline and Placental Genes Identifies Aggressive Metastasis-Prone Lung Cancers
Sophie Rousseaux et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
A Purine Nucleotide Biosynthesis Enzyme Guanosine Monophosphate Reductase Is a Suppressor of Melanoma Invasion
Joseph A. Wawrzyniak et al.
CELL REPORTS (2013)
The pivotal role of pathology in the management of lung cancer
Morgan R. Davidson et al.
JOURNAL OF THORACIC DISEASE (2013)
Histologic patterns and molecular characteristics of lung adenocarcinoma associated with clinical outcome
Luisa M. Solis et al.
CANCER (2012)
Identification of Genes Upregulated in ALK-Positive and EGFR/KRAS/ALK-Negative Lung Adenocarcinomas
Hirokazu Okayama et al.
CANCER RESEARCH (2012)
Adenylate Kinase-4 Is a Marker of Poor Clinical Outcomes That Promotes Metastasis of Lung Cancer by Downregulating the Transcription Factor ATF3
Yi-Hua Jan et al.
CANCER RESEARCH (2012)
p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma
Justin A. Bishop et al.
MODERN PATHOLOGY (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Abnormalities of the TITF-1 Lineage-Specific Oncogene in NSCLC: Implications in Lung Cancer Pathogenesis and Prognosis
Ximing Tang et al.
CLINICAL CANCER RESEARCH (2011)
New driver mutations in non-small-cell lung cancer
William Pao et al.
LANCET ONCOLOGY (2011)
ALK Inhibition for Non-Small Cell Lung Cancer: From Discovery to Therapy in Record Time
David E. Gerber et al.
CANCER CELL (2010)
Clinicopathological characteristics of resected adenosquamous cell carcinoma of the lung: Risk of coexistent double cancer
Hidetaka Uramoto et al.
JOURNAL OF CARDIOTHORACIC SURGERY (2010)
The Evolving Role of Histology in the Management of Advanced Non-Small-Cell Lung Cancer
Corey J. Langer et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Targeted therapy in non-small-cell lung cancer-is it becoming a reality?
Filip Janku et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
The Control of the Metabolic Switch in Cancers by Oncogenes and Tumor Suppressor Genes
Arnold J. Levine et al.
SCIENCE (2010)
Enzymatically inactive adenylate kinase 4 interacts with mitochondrial ADP/ATP translocase
Rujuan Liu et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)
Modulation of Cell Motility by Spatial Repositioning of Enzymatic ATP/ADP Exchange Capacity
Remco van Horssen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors
D. Chitale et al.
ONCOGENE (2009)
The biology of cancer: Metabolic reprogramming fuels cell growth and proliferation
Ralph J. DeBerardinis et al.
CELL METABOLISM (2008)
Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study
Kerby Shedden et al.
NATURE MEDICINE (2008)
Identical epidermal growth factor receptor mutations in adenocarcinomatous and squamous cell carcinomatous components of adenosquamous carcinoma of the lung
Shin Myung Kang et al.
CANCER (2007)
Transcriptional profiling identifies cyclin D1 as a critical downstream effector of mutant epidermal growth factor receptor signaling
Susumu Kobayashi et al.
CANCER RESEARCH (2006)
Mutations of epidermal growth factor receptor and K-ras genes in adenosquamous carcinoma of the lung
S Toyooka et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain
W Pao et al.
PLOS MEDICINE (2005)
EGFR mutation and resistance of non-small-cell lung cancer to gefitinib
S Kobayashi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Gene expression profiling of tumours derived from rasV12/EIA-transformed mouse embryonic fibroblasts to identify genes required for tumour development
Sophie Vasseur et al.
MOLECULAR CANCER (2005)
Two structurally distinct and spatially compartmentalized adenylate kinases are expressed from the AK1 gene in mouse brain
E Janssen et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2004)
Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer - A randomized trial
MG Kris et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes
VK Mootha et al.
NATURE GENETICS (2003)
Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer
M Fukuoka et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
分享论文
